It's Time to Rethink Patient Engagement Strategy
Mar 29, 2022
1 min read
If the clinical trial industry is serious about promoting diversity, it's time to take a holistic approach to patient outreach and eschew its current "transactional" nature, says Chris Komelasky, CEO of SiteBridge Research.



Comments